Lisata Therapeutics Inc. Asset Resilience Ratio

Latest as of December 2025: 0.00%

Lisata Therapeutics Inc. asset resilience ratio. Lisata Therapeutics Inc. (LSTA) has an Asset Resilience Ratio of 0.00% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Lisata Therapeutics Inc. defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$0.00

Cash + Short-term Investments

Total Assets

$17.74 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Lisata Therapeutics Inc. (1999–2025)

Asset resilience ratio of Lisata Therapeutics Inc. from 1999 to 2025. This chart shows how Lisata Therapeutics Inc.'s Asset Resilience Ratio has changed over time. Read Lisata Therapeutics Inc. debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Lisata Therapeutics Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Lisata Therapeutics Inc. assets under control.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$0.00	0%
Total Liquid Assets	$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Lisata Therapeutics Inc. maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Lisata Therapeutics Inc. Industry Peers by Asset Resilience Ratio

Compare Lisata Therapeutics Inc.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Lisata Therapeutics Inc. Asset Resilience Ratio by Year (1999–2025)

Lisata Therapeutics Inc. asset resilience ratio by year from 1999 to 2025. The table below shows the annual Asset Resilience Ratio data for Lisata Therapeutics Inc..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.00%	$0.00	$17.74 Million	--
2024-12-31	42.96%	$15.04 Million	$35.00 Million	-8.13pp
2023-12-31	51.09%	$27.94 Million	$54.69 Million	+0.33pp
2022-12-31	50.76%	$37.07 Million	$73.03 Million	-21.73pp
2021-12-31	72.49%	$70.32 Million	$97.01 Million	+22.33pp
2020-12-31	50.17%	$18.06 Million	$36.00 Million	+9.20pp
2019-12-31	40.97%	$11.12 Million	$27.15 Million	-32.50pp
2018-12-31	73.47%	$32.75 Million	$44.58 Million	+32.58pp
2017-12-31	40.89%	$25.92 Million	$63.38 Million	+35.29pp
2014-12-31	5.61%	$7.08 Million	$126.28 Million	+5.61pp
2011-12-31	0.00%	$559.00	$155.33 Million	+0.00pp
2010-12-31	0.00%	$512.00	$143.02 Million	-81.87pp
2001-12-31	81.87%	$1.50 Million	$1.84 Million	+30.41pp
2000-12-31	51.46%	$2.38 Million	$4.62 Million	-1.41pp
1999-12-31	52.86%	$2.73 Million	$5.17 Million	--

pp = percentage points

About Lisata Therapeutics Inc.

NASDAQ:LSTA USA Biotechnology

Market Cap

$11.78 Million

Market Cap Rank

#26566 Global

#5553 in USA

Share Price

$1.09

Change (1 day)

+7.92%

52-Week Range

$0.99 - $5.04

All Time High

$205.50